Congratulations to Keythera for advancing to the final of the 10ᵗʰ China Innovation and Entrepreneurship Competition with the first-place score in the group stage.

Guided by the important thoughts of General Secretary Xi Jinping on scientific and technological innovation, the 10ᵗʰ China Innovation and Entrepreneurship Competition has received registrations from 33,289 companies in 37 regional divisions across the country since its launch in June this year, including 4,931 in the field of biological medicine. After multiple rounds of selection in the regional competitions, 340 outstanding participating companies have been shortlisted for the national competition in the biopharmaceutical sector. From October 11ᵗʰ to 13ᵗʰ, the national competition for biopharmaceuticals of the 10th China Innovation and Entrepreneurship Competition was held in Hangzhou High-tech Zone. This competition will select 12 outstanding companies in the biopharmaceutical industry and a total of 50 companies from other industries to advance to the national finals. Keythera Biopharmaceuticals, after fierce competition, successfully advanced to the final of the 10th China Innovation and Entrepreneurship Competition with a first-place score in the group stage.

Keythera Biopharmaceuticals is dedicated to the development of new drugs for tumors and autoimmune diseases. The company possesses an affinity-based high-throughput screening platform and, based on this platform, rapidly establishes a research and development pipeline primarily focused on early-stage and original drugs. The core team of the company has extensive experience in global drug development and an international perspective, with backgrounds covering various fields of drug research and development, including chemistry, biology, and clinical medicine.

In this competition, Keythera Biopharmaceuticals' self-developed product, KF-0210, received recognition from the judges for its unique innovation. Dr. Jia Yanlin, Vice President of Keythera Biopharmaceuticals, expressed in an interview with China High-tech Industry Daily after the competition, "Participating in this competition, we felt the strong atmosphere of innovation and entrepreneurship. With the strong support from the country for innovative and entrepreneurial enterprises, I believe that China's new drug R&D and pharmaceutical industry will achieve rapid development in the near future. Keythera Biopharmaceuticals is honored to be part of this wave and will strive to make its own contribution to benefiting patients."

Back to List